BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10424421)

  • 1. Interference of eukaryotic signalling pathways by the bacteria Yersinia outer protein YopJ.
    Spiik AK; Meijer LK; Ridderstad A; Pettersson S
    Immunol Lett; 1999 Jun; 68(2-3):199-203. PubMed ID: 10424421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREB.
    Meijer LK; Schesser K; Wolf-Watz H; Sassone-Corsi P; Pettersson S
    Cell Microbiol; 2000 Jun; 2(3):231-8. PubMed ID: 11207579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.
    Palmer LE; Pancetti AR; Greenberg S; Bliska JB
    Infect Immun; 1999 Feb; 67(2):708-16. PubMed ID: 9916081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity.
    Schesser K; Spiik AK; Dukuzumuremyi JM; Neurath MF; Pettersson S; Wolf-Watz H
    Mol Microbiol; 1998 Jun; 28(6):1067-79. PubMed ID: 9680199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK.
    Palmer LE; Hobbie S; Galán JE; Bliska JB
    Mol Microbiol; 1998 Mar; 27(5):953-65. PubMed ID: 9535085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
    Zhang Y; Ting AT; Marcu KB; Bliska JB
    J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.
    Orth K; Palmer LE; Bao ZQ; Stewart S; Rudolph AE; Bliska JB; Dixon JE
    Science; 1999 Sep; 285(5435):1920-3. PubMed ID: 10489373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.
    Sweet CR; Conlon J; Golenbock DT; Goguen J; Silverman N
    Cell Microbiol; 2007 Nov; 9(11):2700-15. PubMed ID: 17608743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
    Orth K; Xu Z; Mudgett MB; Bao ZQ; Palmer LE; Bliska JB; Mangel WF; Staskawicz B; Dixon JE
    Science; 2000 Nov; 290(5496):1594-7. PubMed ID: 11090361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.
    Shuto T; Xu H; Wang B; Han J; Kai H; Gu XX; Murphy TF; Lim DJ; Li JD
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8774-9. PubMed ID: 11438700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.
    Mukherjee S; Keitany G; Li Y; Wang Y; Ball HL; Goldsmith EJ; Orth K
    Science; 2006 May; 312(5777):1211-4. PubMed ID: 16728640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells.
    Zhou L; Tan A; Hershenson MB
    Respir Physiol Neurobiol; 2004 Apr; 140(1):89-97. PubMed ID: 15109931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell invasion and IL-8 production pathways initiated by YadA of Yersinia pseudotuberculosis require common signalling molecules (FAK, c-Src, Ras) and distinct cell factors.
    Eitel J; Heise T; Thiesen U; Dersch P
    Cell Microbiol; 2005 Jan; 7(1):63-77. PubMed ID: 15617524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Susa S; Tominaga M; Daimon M; Kato T
    Eur J Clin Invest; 2001 Aug; 31(8):672-80. PubMed ID: 11473568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
    Lindroos PM; Rice AB; Wang YZ; Bonner JC
    J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
    Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
    Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner.
    Takehana K; Sato S; Kobayasi T; Maeda T
    Biochem Biophys Res Commun; 1999 Apr; 257(1):19-23. PubMed ID: 10092503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.